Randomized double-blind study of denosumab versus zole- dronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. - Henry, DH; Costa, L; Goldwasser, F (J Clin Oncol, 2011)
et al.